News - North America, Pricing


Current filters:

North AmericaPricing

Popular Filters

1 to 25 of 84 results

Patent lawyer seeking US Senate seat proposes patent reform to lower Rx drug costs


Republican Art Gardner, a patent attorney seeking election to the US Senate in Georgia, has issued a…

North AmericaPatentsPharmaceuticalPoliticsPricingUSA

US lawmakers question price of Gilead’s Sovaldi

US lawmakers question price of Gilead’s Sovaldi


Three leading US Congressmen have written to John Martin, chief executive of US biotech firm Gilead Sciences,…

Anti-viralsBiotechnologyGilead SciencesNorth AmericaPoliticsPricingRegulationSovaldiUSA

Call for Medicaid formularies to block Gilead’s $1,000 per pill hepatitis drug

Call for Medicaid formularies to block Gilead’s $1,000 per pill hepatitis drug


In a series of letters to be sent to state Medicaid directors starting this week, Michael Weinstein,…

Anti-viralsBiotechnologyGilead SciencesNorth AmericaPricingSovaldiUSA

US FDA approval for Gilead's hepatitis C drug Sovaldi

US FDA approval for Gilead's hepatitis C drug Sovaldi


US antiviral biotech specialist Gilead Sciences says that the Food and Drug Administration has approved…

Anti-viralsBiotechnologyGilead SciencesNorth AmericaPricingRegulationsofosbuvirSovaldi

AHF sues Abbott and AbbVie for overcharging on AIDS drug pricing

AHF sues Abbott and AbbVie for overcharging on AIDS drug pricing


In further legal action against drugmakers allegedly over pricing AIDS drugs in the USA, the AIDS Healthcare…

Abbott LaboratoriesAbbVieAnti-viralsKaletra TabletsLegalNorth AmericaNorvirPharmaceuticalPricing

AHF sues Johnson & Johnson over AIDS drug pricing

AHF sues Johnson & Johnson over AIDS drug pricing


The Washington DC, USA-based AIDS Healthcare Foundation (AHF) has filed a law suit in the Superior Court…

Anti-viralsJanssenJohnson & JohnsonLegalNorth AmericaPharmaceuticalPricing

Biosimilars uptake likely more rapid in USA than in Europe


The US drug channel is likely to exhibit a higher acceptance of biosimilars, copy versions of biological…

BiosimilarsEuropeMarkets & MarketingNorth AmericaPricing

US infectious disease specialists’ prescribing choices for GNIs

US infectious disease specialists’ prescribing choices for GNIs


A majority of US surveyed infectious disease specialists are willing to prescribe novel antibiotics if…

Antibiotics and Infectious diseasesMarkets & MarketingNorth AmericaPharmaceuticalPricing

US Senator seeks answers from drugmakers on providing required discounts


US Senator Charles Grassley has written to two drug companies on behalf of an Iowa hospital that is not…

CSL BehringExparelHematologyKcentraNeurologicalNorth AmericaPacira PharmaceuticalsPharmaceuticalPoliticsPricing

AHF sues GSK for failing to provide discounts on HIV/AIDS drugs


The USA-based AIDS Healthcare Foundation (AHF) said yesterday (September 10) that it has filed a law…

Anti-viralsGlaxoSmithKlineLegalNorth AmericaPharmaceuticalPricing

Bayer in settlement over Cipro pricing


A partial settlement has been reached in a US class action law suit involving the prescription antibiotic…

Antibiotics and Infectious diseasesBayerCiproGenericsLegalNorth AmericaPharmaceuticalPricing

Mixed US views on Gilenya, Aubagio and Tecfidera as breakthrough MS drugs


More than half of surveyed neurologists consider US biotech firm Biogen Idec's (Nasdaq: BIIB) Tecfidera…

AubagioBiogen IdecGilenyaMarkets & MarketingNeurologicalNorth AmericaNovartisPharmaceuticalPricingSanofiTecfidera

Drug swap drives down costs for US Medicare


Therapeutic drug substitutions have the potential to double or even triple annual cost savings compared…

FinancialGenericsHealthcareNorth AmericaPricing

Health care reforms not keeping pace with needs of Canadians, says report


The Health Council of Canada today (May 23) released Progress Report 2013: Health care renewal in Canada,…

HealthcareNorth AmericaPharmaceuticalPricing

US Senator Grassley questions continue about 340B discount drug program


US Senator Chuck Grassley (Republican, Iowa) is looking into how hospitals are using a discount prescription…

North AmericaPharmaceuticalPoliticsPricing

Court rules in novel False Claims Act case where one pharma firm sues another viewed by HP&M lawyer


The US District Court for the Central District of California issued a ruling recently in an unusual,…

AmphastarGenericsLegalLovenoxNorth AmericaPharmaceuticalPricingSanofi

High leukemia treatment costs may be harming patients, say experts


The increasing cost of treatments for chronic myeloid leukemia (CML) in the USA has reached unsustainably…

North AmericaOncologyPharmaceuticalPricing

Legislation would undermine USA's Medicare Part D, argues PhRMA


Several members of the US Congress this week echoed President Barack Obama's recycling of a "flawed policy…

HealthcareLegalNorth AmericaPharmaceuticalPricing

US Senator calls for re-examination of pricing of drugs developed with public funds


US Senator Ron Wyden (Democrat, Oregon) has released a letter written to National Institutes of Health…

North AmericaPfizerPharmaceuticalPoliticsPricingResearchXeljanz

Independent US drugstore lobby wants sweeping Antitrust exemptions to charge higher prescription drug prices


The independent drugstore lobby is again seeking special antitrust exemptions (HR 1188) that would empower…

LegalNorth AmericaPharmaceuticalPricing

Unnecessary drug regulations hiking Rx prices in USA: NCPA Study


As drug coverage increases as a result of expanded health insurance and Medicaid coverage under the USA's…

BiotechnologyNorth AmericaPharmaceuticalPricingRegulation

Vivus announces new discount program for obesity drug Qsymia


US drugmaker Vivus (Nasdaq: VVUS) has announced a new program offering eligible patients a discount on…

Markets & MarketingMetabolicsNorth AmericaPharmaceuticalPricingQsymiaVivus

US health care law allows consumers to easily find and compare options, says HHS Secretary


US Department of Health and Human Services (HHS) Secretary Kathleen Sebelius yesterday announced a final…

FinancialHealthcareNorth AmericaPharmaceuticalPricing

Rise in drug costs to US hospitals and clinics slowing in 2013


Although medicine costs will continue to rise in 2013 by as much as 4%, the increase is projected to…

Markets & MarketingNorth AmericaPharmaceuticalPricing

1 to 25 of 84 results

Back to top